Minireviews
Copyright ©The Author(s) 2024.
World J Hepatol. Feb 27, 2024; 16(2): 177-185
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.177
Table 1 Expression of lipocalin 2 in different viral hepatitis
Sample
Cases
LCN2 level
Ref.
Blood 675 mild chronic hepatitis B, 178 moderate chronic hepatitis B, 199 severe chronic hepatitis B and 317 fulminant hepatitis B, 246 healthy volunteersChronic hepatitis, fulminant hepatitis significantly higher than control[37]
Blood54 patients with HBV-ACLF and 49 patients with CHBHBV-ACLF higher than CHB[38]
Blood and urine64 patients with cirrhosis and 23 control subjectsCirrhosis with hepatorenal syndrome patients is significantly higher than controls, no difference between stable cirrhosis and control[39]
Blood192 patients with chronic liver diseases of variable etiology and clinical severity in comparison to 91 healthy controlsChronic liver diseases were higher than healthy controls
No significant differences between cirrhotic and non-cirrhotic patients
[40]
Blood 48 patients with chronic HCVNot correlated with HCV viral load [41]
Blood87 Egyptian patients with chronic hepatitis C infectionSignificantly decrease after HCV treatment with DAA [42]
Blood102 chronic hepatitis C virus infectionSignificantly increase after HCV treatment with DAA [43]